查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1360318

電子臨床解決方案市場 - 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

eClinical Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 235 Pages | 商品交期: 2-10個工作天內

價格

電子臨床解決方案市場 - 報告範圍

TMR 關於全球電子臨床解決方案市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球電子臨床解決方案市場的收入2017 -2031年期間，考慮2023年為基準年，2031年為預測年。該報告也提供了2023年至2031年全球電子臨床解決方案市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解電子臨床解決方案市場。

市場概況
2023年市場價值 95 億美元
2031 年市場價值 299 億美元
複合年成長率 13.6%

該報告深入研究了全球電子臨床解決方案市場的競爭格局。全球電子臨床解決方案市場中的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球電子臨床解決方案市場參與者的屬性。

目錄

第 1 章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 技術進步
  • 監管場景：按地區
  • 價值鏈分析
  • COVID-19 對產業的影響

第 6 章：全球市場分析與預測：按解決方案類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按解決方案類型，2017-2031
    • 臨床試驗管理系統
    • 電子臨床結果評估
    • 隨機化和試驗供應管理
    • 電子數據收集和臨床數據管理
    • 電子審判主文件
    • 病患招募
    • 監管資訊管理系統
    • 其他
  • 市場吸引力分析：按解決方案類型

第 7 章：全球市場分析與預測：依交付模式

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依交付模式，2017-2031
    • 許可企業/本地
    • 基於網路
    • 其他
    • 基於雲端/軟體即服務 (SaaS)
  • 市場吸引力分析：按交付模式

第 8 章：全球市場分析與預測：依臨床試驗階段

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依臨床試驗階段，2017-2031
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段
  • 市場吸引力分析：依臨床試驗階段

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 製藥與生物技術公司
    • 醫療器材製造商
    • 合約研究組織
    • 其他
  • 市場吸引力分析：按最終用戶

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • ArisGlobal LLC
    • Clario
    • LLC
    • Evidation Health, Inc.
    • Florence Healthcare
    • Advarra, Inc.
    • Dassault Systemes SE (Medidata)
    • Medrio, Inc.
    • Oracle Corporation
    • Parexel Corporation
    • Signant Health
    • Veeva Systems Inc.
    • Viedoc Technologies
    • MedNet Solutions
    • Anju Software, Inc.
    • Other Prominent Players
Product Code: TMRGL25508

eClinical Solutions Market - Scope of Report

TMR's report on the global eClinical solutions market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global eClinical solutions market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global eClinical solutions market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the eClinical solutions market.

Market Snapshot
Market Value in 2023US$ 9.5 Bn
Market Value in 2031US$ 29.9 Bn
CAGR13.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global eClinical solutions market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global eClinical solutions market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global eClinical solutions market.

The report delves into the competitive landscape of the global eClinical solutions market. Key players operating in the global eClinical solutions market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global eClinical solutions market profiled in this report.

Key Questions Answered in Global eClinical Solutions Market Report:

  • What is the sales/revenue generated by eClinical solutions across all regions during the forecast period?
  • What are the opportunities in the global eClinical solutions market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

eClinical Solutions Market - Research Objectives and Research Approach

The comprehensive report on the global eClinical solutions market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global eClinical solutions market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global eClinical solutions market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global eClinical Solutions Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global eClinical Solutions Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Regulatory Scenario, by Region
  • 5.3. Value Chain Analysis
  • 5.4. COVID-19 impact on the Industry

6. Global eClinical Solutions Market Analysis and Forecast, by Solution Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Solution Type, 2017-2031
    • 6.3.1. Clinical Trial Management Systems
    • 6.3.2. Electronic Clinical Outcome Assessment
    • 6.3.3. Randomization & Trial Supply Management
    • 6.3.4. Electronic Data Capture & Clinical Data Management
    • 6.3.5. Electronic Trial Master Files
    • 6.3.6. Patient Recruitment
    • 6.3.7. Regulatory Information Management Systems
    • 6.3.8. Others
  • 6.4. Market Attractiveness Analysis, by Solution Type

7. Global eClinical Solutions Market Analysis and Forecast, by Delivery Mode

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 7.3.1. Licensed Enterprise/On-premise
    • 7.3.2. Web-based
    • 7.3.3. Others
    • 7.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 7.4. Market Attractiveness Analysis, by Delivery Mode

8. Global eClinical Solutions Market Analysis and Forecasts, by Clinical Trial Phase

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 8.3.1. Phase I
    • 8.3.2. Phase II
    • 8.3.3. Phase III
    • 8.3.4. Phase IV
  • 8.4. Market Attractiveness Analysis, by Clinical Trial Phase

9. Global eClinical Solutions Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Pharmaceutical & Biotechnology Companies
    • 9.3.2. Medical Device Manufacturers
    • 9.3.3. Contract Research Organizations
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global eClinical Solutions Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America eClinical Solutions Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Solution Type, 2017-2031
    • 11.2.1. Clinical Trial Management Systems
    • 11.2.2. Electronic Clinical Outcome Assessment
    • 11.2.3. Randomization & Trial Supply Management
    • 11.2.4. Electronic Data Capture & Clinical Data Management
    • 11.2.5. Electronic Trial Master Files
    • 11.2.6. Patient Recruitment
    • 11.2.7. Regulatory Information Management Systems
    • 11.2.8. Others
  • 11.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 11.3.1. Licensed Enterprise/On-premise
    • 11.3.2. Web-based
    • 11.3.3. Others
    • 11.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 11.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 11.4.1. Phase I
    • 11.4.2. Phase II
    • 11.4.3. Phase III
    • 11.4.4. Phase IV
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Pharmaceutical & Biotechnology Companies
    • 11.5.2. Medical Device Manufacturers
    • 11.5.3. Contract Research Organizations
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Solution Type
    • 11.7.2. By Delivery Mode
    • 11.7.3. By Clinical Trial Phase
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe eClinical Solutions Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Solution Type, 2017-2031
    • 12.2.1. Clinical Trial Management Systems
    • 12.2.2. Electronic Clinical Outcome Assessment
    • 12.2.3. Randomization & Trial Supply Management
    • 12.2.4. Electronic Data Capture & Clinical Data Management
    • 12.2.5. Electronic Trial Master Files
    • 12.2.6. Patient Recruitment
    • 12.2.7. Regulatory Information Management Systems
    • 12.2.8. Others
  • 12.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 12.3.1. Licensed Enterprise/On-premise
    • 12.3.2. Web-based
    • 12.3.3. Others
    • 12.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 12.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 12.4.1. Phase I
    • 12.4.2. Phase II
    • 12.4.3. Phase III
    • 12.4.4. Phase IV
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Pharmaceutical & Biotechnology Companies
    • 12.5.2. Medical Device Manufacturers
    • 12.5.3. Contract Research Organizations
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Solution Type
    • 12.7.2. By Delivery Mode
    • 12.7.3. By Clinical Trial Phase
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific eClinical Solutions Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Solution Type, 2017-2031
    • 13.2.1. Clinical Trial Management Systems
    • 13.2.2. Electronic Clinical Outcome Assessment
    • 13.2.3. Randomization & Trial Supply Management
    • 13.2.4. Electronic Data Capture & Clinical Data Management
    • 13.2.5. Electronic Trial Master Files
    • 13.2.6. Patient Recruitment
    • 13.2.7. Regulatory Information Management Systems
    • 13.2.8. Others
  • 13.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 13.3.1. Licensed Enterprise/On-premise
    • 13.3.2. Web-based
    • 13.3.3. Others
    • 13.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 13.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 13.4.1. Phase I
    • 13.4.2. Phase II
    • 13.4.3. Phase III
    • 13.4.4. Phase IV
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Pharmaceutical & Biotechnology Companies
    • 13.5.2. Medical Device Manufacturers
    • 13.5.3. Contract Research Organizations
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Solution Type
    • 13.7.2. By Delivery Mode
    • 13.7.3. By Clinical Trial Phase
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America eClinical Solutions Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Solution Type, 2017-2031
    • 14.2.1. Clinical Trial Management Systems
    • 14.2.2. Electronic Clinical Outcome Assessment
    • 14.2.3. Randomization & Trial Supply Management
    • 14.2.4. Electronic Data Capture & Clinical Data Management
    • 14.2.5. Electronic Trial Master Files
    • 14.2.6. Patient Recruitment
    • 14.2.7. Regulatory Information Management Systems
    • 14.2.8. Others
  • 14.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 14.3.1. Licensed Enterprise/On-premise
    • 14.3.2. Web-based
    • 14.3.3. Others
    • 14.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 14.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 14.4.1. Phase I
    • 14.4.2. Phase II
    • 14.4.3. Phase III
    • 14.4.4. Phase IV
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Pharmaceutical & Biotechnology Companies
    • 14.5.2. Medical Device Manufacturers
    • 14.5.3. Contract Research Organizations
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Solution Type
    • 14.7.2. By Delivery Mode
    • 14.7.3. By Clinical Trial Phase
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa eClinical Solutions Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Solution Type, 2017-2031
    • 15.2.1. Clinical Trial Management Systems
    • 15.2.2. Electronic Clinical Outcome Assessment
    • 15.2.3. Randomization & Trial Supply Management
    • 15.2.4. Electronic Data Capture & Clinical Data Management
    • 15.2.5. Electronic Trial Master Files
    • 15.2.6. Patient Recruitment
    • 15.2.7. Regulatory Information Management Systems
    • 15.2.8. Others
  • 15.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 15.3.1. Licensed Enterprise/On-premise
    • 15.3.2. Web-based
    • 15.3.3. Others
    • 15.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 15.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 15.4.1. Phase I
    • 15.4.2. Phase II
    • 15.4.3. Phase III
    • 15.4.4. Phase IV
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Pharmaceutical & Biotechnology Companies
    • 15.5.2. Medical Device Manufacturers
    • 15.5.3. Contract Research Organizations
    • 15.5.4. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Solution Type
    • 15.7.2. By Delivery Mode
    • 15.7.3. By Clinical Trial Phase
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. ArisGlobal LLC
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Clario
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. eClinical Solutions LLC
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Evidation Health, Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Florence Healthcare
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Advarra, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Dassault Systemes S.E. (Medidata)
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Medrio, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Oracle Corporation
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Parexel Corporation
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Signant Health
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Veeva Systems Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Viedoc Technologies
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview
    • 16.3.14. MedNet Solutions
      • 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.14.2. Product Portfolio
      • 16.3.14.3. Financial Overview
      • 16.3.14.4. SWOT Analysis
      • 16.3.14.5. Strategic Overview
    • 16.3.15. Anju Software, Inc.
      • 16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.15.2. Product Portfolio
      • 16.3.15.3. Financial Overview
      • 16.3.15.4. SWOT Analysis
      • 16.3.15.5. Strategic Overview
    • 16.3.16. Other Prominent Players
      • 16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.16.2. Product Portfolio
      • 16.3.16.3. Financial Overview
      • 16.3.16.4. SWOT Analysis
      • 16.3.16.5. Strategic Overview

List of Tables

  • Table 01: Global eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 02: Global eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 03: Global eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 04: Global eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 05: Global eClinical Solutions Market Value (US$ Bn) Forecast, by Region, 2017-2031
  • Table 06: North America eClinical Solutions Market Value (US$ Bn) Forecast, by Country, 2017-2031
  • Table 07: North America eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 08: North America eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 09: North America eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 10: North America eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 11: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 13: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 14: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 15: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 18: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 19: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 20: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 23: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 24: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 25: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 28: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 29: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 30: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 02: eClinical Solutions Market Value Share, by Solution Type, 2022
  • Figure 03: eClinical Solutions Market Value Share, by Delivery Mode, 2022
  • Figure 04: eClinical Solutions Market Value Share, by Clinical Trial Phase, 2022
  • Figure 05: eClinical Solutions Market Value Share, by End-user, 2022
  • Figure 06: Global eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 07: Global eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 08: Global eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 09: Global eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 10: Global eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 11: Global eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 12: Global eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 13: Global eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 14: Global eClinical Solutions Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 15: Global eClinical Solutions Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 16: North America eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 17: North America eClinical Solutions Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 18: North America eClinical Solutions Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 19: North America eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 20: North America eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 21: North America eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 22: North America eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 23: North America eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 24: North America eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 25: North America eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 26: North America eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 28: Europe eClinical Solutions Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 29: Europe eClinical Solutions Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 30: Europe eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 31: Europe eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 32: Europe eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 33: Europe eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 34: Europe eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 35: Europe eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 36: Europe eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 37: Europe eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 38: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 39: Asia Pacific eClinical Solutions Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 40: Asia Pacific eClinical Solutions Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41: Asia Pacific eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 42: Asia Pacific eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 43: Asia Pacific eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 44: Asia Pacific eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 45: Asia Pacific eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 46: Asia Pacific eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 47: Asia Pacific eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 48: Asia Pacific eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 50: Latin America eClinical Solutions Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 51: Latin America eClinical Solutions Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 52: Latin America eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 53: Latin America eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 54: Latin America eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 55: Latin America eClinical Solutions Market Attractiveness Analysis, by Delivery Mode, 2023-2031
  • Figure 56: Latin America eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 57: Latin America eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 58: Latin America eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 59: Latin America eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 60: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 61: Middle East & Africa eClinical Solutions Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 62: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 63: Middle East & Africa eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 64: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 65: Middle East & Africa eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 66: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 67: Middle East & Africa eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 68: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by Clinical Trial Phase, 2023-2031
  • Figure 69: Middle East & Africa eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 70: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 71: Global eClinical Solutions Market Share Analysis By Company (2022)